top of page
  • Maureen May

The OTC Application Process for Non-Prescription Drugs


The significance of nonprescription drugs cannot be overstated in today's fast-paced world. These over-the-counter (OTC) medications offer accessibility and convenience to millions of individuals seeking relief from common ailments. From painkillers and antacids to allergy and cough remedies, nonprescription drugs provide immediate relief for minor health issues without the need for a doctor's prescription.

The OTC application process for non-prescription drugs is a critical step in ensuring their availability and accessibility to consumers. It ensures that only those medications that meet the necessary criteria are classified as non-prescription. This assessment involves rigorous scientific evaluations to assess the drug's safety, efficacy, and potential for misuse. This article details the OTC application process and steps manufacturers must take to safely bring their product to market.

What are Nonprescription (OTC) Drugs

Defining Nonprescription Drugs

Nonprescription drugs, also known as over-the-counter medications, are medications that can be purchased without a prescription from a healthcare professional. These medications are typically used to treat minor health conditions, such as headaches, allergies, or cold symptoms. They are regulated by the U.S. Food and Drug Administration (FDA) and are considered safe for self-medication when used as directed.

Benefits and Importance of OTC Drugs

Nonprescription drugs offer numerous benefits that make them an essential part of healthcare.

Firstly, they provide immediate relief for common ailments such as headaches, colds, allergies, and digestive issues. This quick relief allows individuals to carry on with their daily activities without the need for a doctor's visit or prescription.

Secondly, nonprescription drugs offer accessibility. They are widely available at pharmacies, supermarkets, and online stores, making them easily accessible to anyone in need. This accessibility ensures that individuals can obtain the medications they need promptly and conveniently.

Furthermore, nonprescription drugs empower individuals to take control of their own health. By providing a range of medications for various health issues, these drugs enable individuals to address their symptoms independently. This self-care approach not only saves time and money but also promotes a sense of empowerment and responsibility for one's own well-being.

Distinguishing Between Prescription and OTC Drugs

The distinction between prescription and nonprescription drugs lies in their potential risks and benefits.

Prescription drugs are often more potent and may have more significant side effects, requiring careful monitoring by a healthcare professional.

Nonprescription drugs, on the other hand, are generally considered safe and effective for self-treatment of minor health issues. Nonprescription drugs can be purchased by the consumer without a prescription and are used to treat common ailments. On the other hand, prescription drugs require a doctor's prescription and are typically used for the treatment of more serious medical conditions.

Nonprescription drugs encompass a wide range of medications that target various health concerns. Some of the most common types of nonprescription drugs include:

  • Painkillers

  • Antacids

  • Allergy Medications

  • Cough and Cold Remedies

  • Topical Creams and Ointments.

Criteria for Nonprescription Status

The criteria for nonprescription drug status serve as a set of guidelines to evaluate the safety, efficacy, and appropriate use of medications intended for over the counter use. These criteria are established by regulatory bodies, such as the FDA, to ensure that nonprescription drugs meet certain standards before they can be sold without a prescription.

Criteria for nonprescription drug status include the following:

  • Safety Profile: The drug must have a low risk of adverse effects when used according to the instructions provided. Clinical trials and safety data are required to demonstrate the drug's safety profile and identify potential risks or side effects.

  • Effectiveness: The drug must be proven to provide relief or treatment for the intended condition when used as directed. Clinical trials and studies are conducted to establish the drug's efficacy and demonstrate its ability to produce the desired therapeutic effects.

  • Ease of Use and Self-Diagnosis: Nonprescription drugs are intended for self-care use, which means consumers must be able to use them safely and effectively without the supervision of a healthcare professional.

  • Potential for Misuse or Abuse: Nonprescription drugs must have a low potential for misuse or abuse. The medication should not pose a significant risk of addiction, dependence, or misuse when used as directed.

Regulatory Information

Overview of the FDA (U.S. Food and Drug Administration)

The primary mission of the FDA is to protect and promote public health by ensuring the safety, effectiveness, and security of human and veterinary drugs, medical devices, our nation's food supply, and cosmetics. To achieve this, the FDA employs a comprehensive approach that involves research, regulatory information, and enforcement.

One of the key responsibilities of the FDA is to evaluate and approve new drugs before they can be marketed and sold to the public. This process involves rigorous testing and clinical trials to ensure that the products are safe and effective for their intended use. The FDA also monitors the safety of approved drugs through post-market surveillance to identify and address any potential risks or adverse events.

Laws and Regulations Governing OTC Drugs


The FDA plays a central role in regulating nonprescription drugs in the United States. Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), the FDA sets forth various provisions to ensure the safety, effectiveness, and proper labeling of nonprescription medications.

Some key provisions of the FD&C Act include:

  • New Drug Product Approval Process

  • Monograph System

  • Labeling and Packaging

  • Adverse Event Reporting.

In addition to regulating the safety and effectiveness of medications, the FDA has established Good Manufacturing Practices (GMP) regulations to ensure the quality, purity, strength, and identity of nonprescription drugs. These regulations define the minimum requirements for facilities, personnel, equipment, and processes involved in the manufacturing, processing, packaging, and storage of nonprescription drugs.

In recent years, FDA has issued a proposed rule aimed at increasing options for manufacturers to develop and market safe and effective nonprescription drugs and increase the types of nonprescription drug products available to consumers.

State Boards of Pharmacy

In addition to regulation by the US FDA, manufacturing  and distribution of OTC drugs may be regulated at the state level.  Every state has an agency responsible for regulating companies engaged in the pharmaceutical supply chain. For most states, the Board of Pharmacy is the delegated agency. Although, other states have delegated authority to agencies such as the Department of Health or Department of Consumer Protection.

The Board of Pharmacy or other responsible agency plays a crucial role in regulating the sale and dispensing of drugs to ensure the protection of public health. Through OTC rulemaking, the Board of Pharmacy regulates to ensure the legal distribution of drugs through the following actions:  

  • Establishing rules for key personnel and facility requirements: The agency establishes rules and regulations outlining the minimum qualifications for personnel, requirements for policies and procedures, and facility construction and condition requirements.

  • Conducting inspections and investigations: The agency conducts routine inspections of facilities to ensure compliance with state and Federal regulations.

  • Issuing and revoking licenses: The agency is responsible for issuing licenses to regulated drug facilities, as well as revoking or suspending licenses in cases of misconduct or failure to comply with regulatory requirements.

Approximately 20 states regulate the manufacturing, distribution and/or sale of OTC drug products in their state. It is critical that companies understand their state licensing requirements, in addition to Federal requirements.

The OTC Application Process

The OTC application process for a non-prescription drug product involves a series of steps to ensure that these products meet the necessary standards for safety and efficacy. The FDA regulates this process, overseeing the development, approval, and marketing of non-prescription drugs.

Choosing Between OTC Monograph and NDA/ANDA Application Pathways

The FDA provides for two regulatory pathways to bring a nonprescription drug product to market in the U.S. One option allows manufacturers to bring OTC drugs to market once they comply with the OTC monograph requirements. The second option includes a drug application process involving submission of an appropriate application for review and approval.

OTC Monograph

OTC monographs are developed for specific OTC drug categories. This includes the active ingredients allowed, dosage forms, labeling requirements, and indications. If the FDA determines that the monograph meets the necessary safety and efficacy standards, the monograph is finalized and published. Manufacturers are then required to comply with the monograph's requirements for their products.

NDA/ANDA Application Process

Under the drug application process, a sponsor of a nonprescription drug submits a New Drug Application (NDA) or an Abbreviated New Drug Application (ANDA) to FDA for approval.  These applications serve as a comprehensive submission of data and information related to the drug's safety, efficacy, labeling, and manufacturing processes. The sponsor cannot market the nonprescription drug until FDA approves the NDA or ANDA.

Step-by-step Guide to OTC Application Process

Pre-Submission Preparations

Submitting a nonprescription drug for approval requires careful planning and preparation. This stage is crucial for ensuring that the drug meets all the necessary requirements and regulations. By taking the time to complete these pre-submission preparations, potential delays and setbacks in the approval process can be avoided.

One of the key reasons pre-submission preparations are important is that they allow for extensive market research. Understanding the target market for the nonprescription drug is essential for its success. By researching market trends, consumer needs, and competitor products, valuable insights can be gained that will inform drug development and marketing strategies.

Another important aspect of pre-submission preparations is understanding the regulatory requirements for nonprescription drugs. Each regulatory authority has specific guidelines that must be followed. These guidelines cover various aspects such as labeling, packaging, safety, and efficacy. Becoming familiar with these requirements early on will help ensure that the drug meets all necessary criteria.


Completing NDA and ANDA Submission

Submitting a nonprescription drug for approval requires completing NDA or ANDA required documentation and forms. These documents serve as evidence of the drug's safety, efficacy, and compliance with regulatory requirements. It's crucial to complete these documents accurately and thoroughly to avoid any delays or rejections.

One of the key documents is the drug application, which typically includes information about the drug's formulation, manufacturing process, safety data, and clinical trial results. This application serves as a comprehensive overview of the nonprescription drug and should provide all the necessary information to support its approval.

In addition to the drug application, other supporting documents may be required, such as stability data, labeling and packaging specifications, and any additional studies or reports required by the regulatory authority. It's important to gather and organize these documents in a systematic manner to ensure a smooth submission process.

FDA Drug Review Process

Once the NDA or ANDA is submitted, the FDA begins its drug review process, which typically takes several months to complete. The review process involves an in-depth evaluation of the data provided in the drug application, including a thorough analysis of the drug's safety and efficacy. The FDA assesses whether the drug's benefits outweigh its potential risks and evaluates the proposed labeling and usage instructions to ensure they are accurate and informative.

During the drug review process, the FDA may request additional information or clarification from the pharmaceutical company. This back-and-forth communication helps to ensure that the FDA has a comprehensive understanding of the drug and its potential benefits and risks.

Once the drug review process is complete, the FDA will update the application status and make a decision regarding the approval of the new drug. If the drug is approved, it can be marketed and distributed to consumers.

Labeling and Packaging Requirements

Labeling requirements are one of the key aspects of ensuring patient safety. Misunderstanding or misinterpreting drug labels can have serious consequences, such as overdosing or adverse drug reactions. These consequences highlight the importance of supporting drug label comprehension and ensuring that patients have the necessary knowledge to use medications safely.

Nonprescription drugs must have clear and accurate labeling that includes important information such as the drug's active ingredients, directions for use, warnings, and precautions. It's essential to ensure that labeling meets all the necessary guidelines to avoid any potential issues during the approval process.

Packaging requirements are another crucial aspect to consider. Nonprescription drugs must be packaged in a way that ensures their safety, stability, and integrity. This includes factors such as appropriate container materials, child-resistant packaging, and tamper-evident features. Understanding and implementing these packaging regulations will help manufacturers meet the necessary standards.

Post-Approval Responsibilities

Once a drug receives US FDA approval, drug manufacturers have a crucial role in monitoring and maintaining the safety and efficacy of their product. Post-approval responsibilities are essential to ensure that the drug continues to meet the required standards and remains safe for consumer use.

One of the primary post-approval responsibilities of drug manufacturers is the reporting of adverse events. Adverse events are any undesirable medical occurrences associated with the use of a drug. Manufacturers are required to collect and analyze data on adverse events and promptly report them to regulatory authorities. This information is crucial for identifying and addressing potential safety concerns and ensuring patient safety.

State Licensing of OTC Drugs

In addition to obtaining required FDA drug approval, companies must understand and comply with state OTC drug licensing regulations. Approximately 20 US states require licensure or registration to manufacture, distribute, or sell OTC drugs into their state.

Unfortunately, there is no uniform standard for state licensing and requirements for applying for and maintaining licenses vary widely across every state. To understand each state OTC drug licensing requirement, companies must navigate complex state statutes and regulations. In addition, regulations are ever-changing and amendments to licensing requirements must be closely monitored.

Failure to obtain required state OTC drug registration or licenses can result in administrative penalties and inability to distribute and sell OTC drugs into the state. It is crucial for companies engaged in OTC drug manufacturing and distribution to engage with regulatory experts to navigate the complex licensing process and ensure compliance with all applicable regulations.

Complete Compliance Solutions assists companies with addressing their state OTC drug licensing requirements. Contact Complete Compliance Solutions to learn more about our state OTC drug licensing services.


Navigating the OTC application process for non-prescription drugs requires a thorough understanding of regulatory requirements, the FDA drug review process, labeling and packaging requirements, and post-approval responsibilities. Manufacturers must also be aware of and comply with state OTC drug licensing and registration regulations. By following the appropriate steps, manufactures can bring safe and effective non-prescription drugs to the market, improving public health and providing consumers with a wider range of options for self-care.

Author: Maureen May

Disclaimer: The information provided in this article is for informational purposes only and should not be considered legal or regulatory advice.


bottom of page